AUROMOX

• Moxifloxacin Ophthalmic Solution 0.5 % w/v

• Auromox (Moxifloxacin hydrochloride) administration prevents post-operative anterior chamber reaction

• Reduces the chance of endophthalmitis by 3.5 fold (3 fold for m-SICS and nearby 6-fold for phcoemulsification)

• Each of Aurolab's products are made in India, to world-class standards

• Proved Non-toxic in terms of visual rehabilitation, anterior chamber reaction and corneal edema

• The MIC level of moxifloxacin is maintained in the anterior chamber for a period of 5 hours making it an effective antibiotic agent for prophylaxis

• Auromox formulated with ideal pH and Osmolality that is compatible with the human anterior chamber fluid

• No stromal edema and no drug related adverse effects

• Auromox comes in 1 ml USP type 1 Borosilicate chemical resistance glass container.

0.1 ml of Auromox is indicated as prophylaxis antibiotic per patient.